Distinct prognostic values of Annexin family members expression in acute myeloid leukemia
- 25 Downloads
Annexin family consist of 12 members, many of them are frequently dysregulated in human cancers. However, the diagnosis and prognosis of Annexin family expression in acute myeloid leukemia (AML) remain elusive. The aim of the present study was to assess the prognostic value of Annexin expressions in adult and pediatric AML.
GenomicScape tool was used to assess the prognostic value of the expressions of Annexin family members in a cohort of 162 adult AML patients. Quantitative reverse transcript real-time PCR (QRT-PCR) was performed to detect the ANXA2 expression level in the bone marrow-derived mononuclear cells (BMMCs) obtained from 101 pediatric AML patients and 30 controls.
The results demonstrated that high mRNA expressions of ANXA2, ANXA6, and ANXA7 were significantly associated with worse prognosis, while ANXA5 was correlated with better prognosis in adult AML. QRT-PCR analysis showed that ANXA2 expression was dramatically downregulated in BMMCs of pediatric AML patients compared to controls (p < 0.0001). ROC analysis demonstrated that ANXA2 could efficiently differentiate pediatric AML patients from controls (AUC 0.872, p < 0.0001). Likewise, ANXA2 was significantly lower in AML patients with poor-risk karyotype (p = 0.048). Also, the level of ANXA2 trended to decrease in AML patients who had not achieving complete remission. Moreover, patients with lower expression of ANXA2 had higher death rate (p = 0.042) and shorter overall survival (HR 0.55, p = 0.042). Thus, these findings suggest that ANXA2 exerts poor prognostic effect on adult AML but favorable prognostic effect on pediatric AML.
Collectively, Annexin family members exert distinct prognostic roles in AML, and ANXA2 can be used as a biological marker for diagnosis and prognosis of pediatric AML.
KeywordsAcute myeloid leukemia Prognostic biomarker Annexin family ANXA2
Conceived and designed the experiment: HW, YN; Performed the experiments: XY, YC, XJ, LL; Patients sample preparation: LZ, YT, SL, YG.
This work was supported by National Natural Science Foundation of China (Grant nos. 81701554 and 81702099), and Natural Science Foundation of Henan Province (Grant no. 162300410213).
Compliance with ethical standards
Conflict of interest
No potential conflicts of interests were disclosed.
The study was approved by the Scientific Committee on Research and Ethics of the Children Hospital of Soochow University.
Informed consent was obtained from all individual participants included in the study.
- 15.D’Souza S, Kurihara N, Shiozawa Y, Joseph J, Taichman R, Galson DL, et al. Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment. Blood. 2012;119(8):1888–96. https://doi.org/10.1182/blood-2011-11-393348.CrossRefGoogle Scholar
- 17.Spijkers-Hagelstein JA, Mimoso Pinhancos S, Schneider P, Pieters R, Stam RW. Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia. 2013;27(5):1063–71. https://doi.org/10.1038/leu.2012.372.CrossRefGoogle Scholar
- 19.Weston-Bell NJ, Hendriks D, Sugiyarto G, Bos NA, Kluin-Nelemans HC, Forconi F, et al. Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins. Leukemia. 2013;27(1):241–5. https://doi.org/10.1038/leu.2012.163.CrossRefGoogle Scholar
- 20.Handschuh L, Kazmierczak M, Milewski MC, Goralski M, Luczak M, Wojtaszewska M, et al. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR. Int J Oncol. 2018;52(3):656–78. https://doi.org/10.3892/ijo.2017.4233.Google Scholar
- 22.Zhang LY, Jiang M, Li X, Shen F, Jia R, Ruan CG. Expression of annexin II in patients with hematologic malignancies. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009;17(3):529–32.Google Scholar
- 23.Kassambara A, Reme T, Jourdan M, Fest T, Hose D, Tarte K, et al. GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells. PLoS Comput Biol. 2015;11(1):e1004077. https://doi.org/10.1371/journal.pcbi.1004077.CrossRefGoogle Scholar
- 24.Basso K, Liso A, Tiacci E, Benedetti R, Pulsoni A, Foa R, et al. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med. 2004;199(1):59–68. https://doi.org/10.1084/jem.20031175.CrossRefGoogle Scholar
- 26.Szczepanek J, Laskowska J, Lewandowska-Bieniek J, Tretyn A, Styczynski J. Array-based genomic and transcriptomic profiling in pediatric acute leukemias in search of genes responsible for cyclophosphamide resistance. Blood. 2014;124(21):3802.Google Scholar
- 27.Proto-Siqueira R, Panepucci RA, Careta FP, Lee A, Clear A, Morris K, Owen C, Rizzatti EG, Silva WA Jr, Falcão RP, Zago MA, Gribben JG. SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. Blood. 2008;112(2):394–7. https://doi.org/10.1182/blood-2007-11-124065.CrossRefGoogle Scholar
- 28.Lindberg ML, Haag P, Moshfegh A, Kanter L, Bjorkholm M, Lewensohn R, Kristina V, Stenke L. Gene expression analyses at time of diagnosis indicate biomarkers predictive of therapeutic response in acute myeloid leukemia. Blood. 2013;122(21):2619.Google Scholar
- 29.Chitteti BR, Poteat B, Wang M, Liu Y, Srour EF. Genetic and proteomic analysis of functionally distinct human hematopoietic stem cells from bone marrow, mobilized peripheral blood, and cord blood. Blood. 2008;112(11):1324.Google Scholar
- 31.Tsai WH, Chien HY, Shih CH, Lai SL, Li IT, Hsu SC, et al. Annexin A1 mediates the anti-inflammatory effects during the granulocytic differentiation process in all-trans retinoic acid-treated acute promyelocytic leukemic cells. J Cell Physiol. 2012;227(11):3661–9. https://doi.org/10.1002/jcp.24073.CrossRefGoogle Scholar
- 34.Tumino M, Accordi B, Sciro M, Milani G, Tognazzo F, Giordan M, Kronnie TT, Basso G, Nigro LL. Expression of Annexin 2 in pediatric B-acute lymphoblastic leukemia: a marker of aggressiveness and a potential therapeutic target. Blood. 2009;114(22):2605.Google Scholar
- 35.Chang KS, Wang G, Freireich EJ, Daly M, Naylor SL, Trujillo JM, et al. Specific expression of the annexin VIII gene in acute promyelocytic leukemia. Blood. 1992;79(7):1802–10.Google Scholar
- 36.Payton JE, Grieselhuber NR, Chang LW, Murakami MA, Yuan W, Link DC, Nagarajan R, Watson MA, Ley TJ. The expression signature of M3 AML suggests direct and indirect effects of PML-RARA on target genes. Blood. 2007;110(11):719.Google Scholar
- 37.Sarkar A, Yang P, Fan YH, Mu ZM, Hauptmann R, Adolf GR, et al. Regulation of the expression of annexin VIII in acute promyelocytic leukemia. Blood. 1994;84(1):279–86.Google Scholar
- 41.Rossetti S, Bshara W, Reiners JA, Corlazzoli F, Miller A, Sacchi N. Harnessing 3D models of mammary epithelial morphogenesis: an off the beaten path approach to identify candidate biomarkers of early stage breast cancer. Cancer Lett. 2016;380(2):375–83. https://doi.org/10.1016/j.canlet.2016.07.003.CrossRefGoogle Scholar